{"schema_version":"secwatch.filing_event.v1","accession":"0001412408-23-000017","form_type":"8-K","ticker":"PHR","cik":"0001412408","company_name":"Phreesia, Inc.","filed_at":"2023-03-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.831234+00:00","generated_at":"2026-06-17T21:12:08.000634+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Phreesia Q4 FY2023 revenue $76.6M (+32% YoY); FY2024 guidance revenue $353-356M","bullets":["Q4 revenue $76.6M (+32% YoY); net loss $38.0M vs $46.5M loss year ago; Adj. EBITDA -$17.6M vs -$30.5M.","AHSCs 3,140 (+36% YoY); Healthcare services revenue per AHSC $17,705 (-4% YoY).","Full year revenue $280.9M (+32%); net loss $176.1M vs $118.2M prior year; Adj. EBITDA -$92.5M.","FY2024 outlook: revenue $353-356M (26-27% growth); Adj. EBITDA loss -$65M to -$60M (improvement).","Cash $176.7M at Jan 31; transferred funds from SVB on March 9 before FDIC receivership; all cash available."],"urls":{"canonical":"https://secwatch.observer/filing/0001412408-23-000017","json":"https://secwatch.observer/filing/0001412408-23-000017.json","markdown":"https://secwatch.observer/filing/0001412408-23-000017.md","text":"https://secwatch.observer/filing/0001412408-23-000017.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1412408/000141240823000017/0001412408-23-000017-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1412408/000141240823000017/phr-20230322.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T21:12:08.000634+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"42275f5edfcb92d17a8a855934416cab605b69be","claim":"Phreesia, Inc. reported FY2024 ending January 31, 2024 results: revenue $353 million to $356 million. Guidance initiated.","evidence_excerpt":"For the full fiscal year 2024 ending January 31, 2024, we expect revenue to be between $353 million and $356 million, implying year-over-year growth of 26% to 27%.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1412408/000141240823000017/0001412408-23-000017-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"FY2024 ending January 31, 2024"},{"label":"Revenue","value":"$353 million to $356 million"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"4804a1d7471f6fa2b9acc26945ad5f65141b9ef2","claim":"Phreesia, Inc. reported Q4 FY2023 ended January 31, 2023 results: revenue $76.6 million, net income $38.0 million.","evidence_excerpt":"• Revenue was $76.6 million in the quarter, up 32% year-over-year. • Average number of healthcare services clients (\"AHSCs\") was 3,140 in the quarter, up 36% year-over-year. • Healthcare services revenue per AHSC was $17,705 in the quarter, down 4% year-over-year. The decline was primarily driven by healthcare services client growth significantly outpacing growth in payment processing volume and payment processing revenue. See \"Key Metrics\" below for additional information. • Total revenue per AHSC was $24,390 in the quarter, down 3% year-over-year. The decline was primarily driven by healthcare services client growth significantly outpacing growth in payment processing volume and payment processing revenue. See \"Key Metrics\" below for additional information. • Net loss was $38.0 million in the quarter compared to $46.5 million in the same period in the prior year.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1412408/000141240823000017/0001412408-23-000017-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Q4 FY2023 ended January 31, 2023"},{"label":"Revenue","value":"$76.6 million"},{"label":"Net income","value":"$38.0 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}